A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine

NCT03581903 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: H7N3 pLAIV
BIOLOGICAL: H7N9 pIIV

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)